Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Dec;32(6):903-914.
doi: 10.1016/j.hoc.2018.07.003. Epub 2018 Sep 28.

Early Detection of Ovarian Cancer

Kevin M Elias  1 , Jing Guo  2 , Robert C Bast Jr  3
Affiliations
Review

Early Detection of Ovarian Cancer

Kevin M Elias et al. Hematol Oncol Clin North Am. 2018 Dec.

Abstract

Early detection of ovarian cancer could reduce mortality by 10% to 30%. Effective screening requires high sensitivity (>75%) and extremely high specificity (99.7%). Clinical trials suggest the best specificity is achieved with 2-stage strategies in which increasing serum CA125 level triggers transvaginal sonography to detect a malignant pelvic mass, although evidence for such approaches improving overall survival has been limited. Screening may be improved by combining CA125 with novel biomarkers, such as autoantibodies, circulating tumor DNA, or microRNAs. In order to detect premetastatic ovarian cancers originating in the distal fallopian tube, more sensitive approaches to diagnostic imaging are required.

Keywords: Autoantibodies; CA125; Early detection; Ovarian cancer; Screening; TP53; ctDNA; miRNA.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Potential Biomarkers for early detection
See this image and copyright information in PMC

References

    1. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin 2017;67(1):7–30. - PubMed
    1. Skates SJ, Singer DE. Quantifying the potential benefit of CA 125 screening for ovarian cancer. J Clin Epidemiol 1991;44(4–5):365–380. - PubMed
    1. Moss HA, Berchuck A, Neely ML, Myers ER, Havrilesky LJ. Estimating Cost-effectiveness of a Multimodal Ovarian Cancer Screening Program in the United States: Secondary Analysis of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). JAMA Oncol 2018;4(2):190–195. - PMC - PubMed
    1. Henderson JT, Webber EM, Sawaya GF. Screening for Ovarian Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 2018;319(6):595–606. - PubMed
    1. Pinsky PF. Principles of Cancer Screening. Surg Clin North Am 2015;95(5):953–966. - PMC - PubMed

Publication types

Substances